Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

In $1.3 billion deal, chip equipper to acquire another

Article Abstract:

KLA Instruments will acquire Tencor Instruments to create KLA-Tencor, a semiconductor equipment company with over $1 billion in revenue and 3,900 employees. The purchase was made through a tax-free stock exchange valued at $1.32 billion. KLA CEO Kenneth Levy will be the KLA-Tencor chairman, while Tencor CEO Jon D. Tompkins will remain chief executive officer for the new company. Both companies manufacture measurement and inspection systems for microprocessor production. Their customers are primarily in the Pacific Rim and Asia. Industry analysts are enthusiastic about the merger, which they say will allow the companies to reduce costs and focus on product development. Tencor shares rose 23% to $37 in after-hours trading Jan 14, 1997. KLA shares rose from $40 to $40.875 before Nasdaq trading was stopped.

Author: Freudenheim, Milt
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: Business, general
ISSN: 0362-4331
Year: 1997
Special industry machinery, not elsewhere classified, Semiconductor Production Equip, Semiconductor Machinery Manufacturing, Semiconductor industry, Mergers, acquisitions and divestments, Semiconductor production equipment, KLAC, KLA Instruments Corp., Company Acquisition/Merger, Tencor Instruments Inc., TNCR

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Pharmaceuticals Present A Paradox

Article Abstract:

The price of pharmaceuticals continue to grow and the amount of drugs bought by consumers has increased. The rising costs are reflective of the costs associated with the research and development as well as advertising. Managed care and government plans to reform medicaid may hinder drug costs which could affect the research and production of new drugs.

Author: Worsham, James
Publisher: U.S. Chamber of Commerce
Publication Name: Nation's Business
Subject: Business, general
ISSN: 0028-047X
Year: 1999
United States, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, Forecasts, trends, outlooks, Drugs, Research, Pharmaceutical industry, Prices and rates, Pharmaceutical research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: E-quality leadership. The quality journey: what I saw, what I heard, what I learned
  • Abstracts: Evolution from quality management to an integrative system in modern business
  • Abstracts: King World agrees to pay $150 million in 'Oprah' deal. Ads to promote using transcripts for jobs
  • Abstracts: Dairy assails bill to alter marketing. Polyphenols put sparkle in Japanese sales. MedPartners ordered by California to halt plan's funds transfer
  • Abstracts: Dow takes on a new, high-technology look. Cheap digital cameras abandon the ordinary
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.